The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 02, 2015
Filed:
Feb. 06, 2013
Applicant:
Inhibrx Llc, La Jolla, CA (US);
Inventors:
Brendan Eckelman, La Jolla, CA (US);
John Timmer, La Jolla, CA (US);
Amir Razai, La Jolla, CA (US);
Quinn Deveraux, La Jolla, CA (US);
Kyle Jones, La Jolla, CA (US);
Peter L. Nguy, La Jolla, CA (US);
Assignee:
InhibRx LLC, La Jolla, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 14/705 (2006.01); A61K 45/06 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); C07K 14/70503 (2013.01); A61K 45/06 (2013.01); A61K 39/39558 (2013.01); C07K 2319/21 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/565 (2013.01); C07K 2317/70 (2013.01); C07K 2317/76 (2013.01);
Abstract
This invention relates generally to monoclonal antibodies that recognize CD47, more specifically to CD47 antibodies that do not cause a significant level of agglutination of cells, to methods of generating these antibodies, and to methods of using these monoclonal antibodies as therapeutics.